1. OP18 Disease course of Crohn's disease during the first ten years following diagnosis in a prospective European population-based inception cohort – the Epi-IBD cohort. (30th January 2023) Authors: Wewer, M D; Salupere, R; Kievit, H A L; Nielsen, K R; Midjord, J; Domislovic, V; Krznarić, Ž; Pedersen, N; Kjeldsen, J; Eriksson, C; Halfvarson, J; Talbot, A; Sebastian, S; Goldis, A; Misra, R; Arebi, N; Ilus, T; Oksanen, P; Neuman, A; Andersen, V Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM. (25th January 2019) Authors: Yzet, C; Ungaro, R; Bossuyt, P; Baert, F; Vanasek, T; D'Haens, G; Joustra, V; Panaccione, R; Novacek, G; Armuzzi, A; Golovchenko, O; Prymak, O; Goldis, A; Travis, S; Hébuterne, X; Ferrante, M; Rogler, G; Fumery, M; Danese, S; Rydzewska, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P130 Intestinal ultrasound combined to fecal calprotectin is effective to predict endoscopic mucosal healing in ulcerative colitis: a cross-sectional study. (30th January 2023) Authors: Yzet, C; Meudjo, E; Moreau, C; Brazier, F; Hautefeuille, V; Decrombecque, C; Sarba, R; Pichois, R; Meynier, J; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P175 Complete endoscopic healing is associated with lower disability than partial mucosal healing in Crohn's disease: a prospective multicentric study. (27th May 2021) Authors: Yzet, C; Brazier, F; Sebbagh, V; Vanelslander, P; Dejour, V; David, B; Nguyen-Khac, E; Diouf, M; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P303 Ultrasound is effective to identify mucosal healing in Crohn's disease patients : results of a cross-sectional study. (30th January 2023) Authors: Yzet, C; Brazier, F; Hautefeuille, V; Decrombecque, C; Sarba, R; aygalenq, P; Venezia, F; Buisson, A; Pichois, R; Michaud, A; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P314 Long-term fate of the excluded rectum in Crohn's disease. (25th January 2019) Authors: Yzet, C; Kassim, G; Nair, N; Colombel, J-F; Sachar, D B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P323 Prognostic factors for long-term adalimumab treatment. (25th January 2019) Authors: Fumery, M; Duveau, N; Perignon, C; Lepeut, G; Lahaye, A; Le Baut, G; Roussillon, C; Yzet, C; Loreau, J; Wils, P; Nachury, M; Pariente, B; Viennot, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P338 Transmural healing is not associated with less disability than complete endoscopic mucosal healing: a prospective study in a patient with Crohn's disease. (30th January 2023) Authors: Yzet, C; Brazier, F; Hautefeuille, V; Grados, L; Decrombecque, C; Diouf, M; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P400 Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH study. (21st January 2022) Authors: Buisson, A; Nachury, M; Reymond, M; Yzet, C; Wils, P; Payen, L; Manlay, L; Pereira, B; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P404 Stopping 5-aminosalicylates in Crohn's disease patients starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts. (25th January 2019) Authors: Ungaro, R; Limketkai, B; Jensen, C B; Yzet, C; Allin, K H; Agrawal, M; Burisch, J; Ullman, T; Jess, T; Colombel, J-F Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗